Polynovo Ltd Cash Flow Conversion Efficiency
Polynovo Ltd cash flow conversion efficiency. Based on the latest financial reports, Polynovo Ltd (PNV) has a cash flow conversion efficiency ratio of 0.110x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$9.16 Million ≈ $6.48 Million USD) by net assets (AU$83.14 Million ≈ $58.83 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Polynovo Ltd (1999–2025)
Cash flow conversion efficiency of Polynovo Ltd from 1999 to 2025. This chart illustrates how Polynovo Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View PNV stock price for real-time trading data and today's change.
Polynovo Ltd Cash Flow Conversion Ratio Explained
Polynovo Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Polynovo Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Polynovo Ltd ranked by their cash flow conversion efficiency. Also see PNV stock market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hebei Gongda Keya Energy Technology Co. Ltd. A
SHE:301197
|
N/A |
|
Better Collective
ST:BETCO
|
0.030x |
|
Groupe Guillin SA
PA:ALGIL
|
0.100x |
|
Tederic Machinery Co Ltd
SHG:603289
|
0.020x |
|
Binh Minh Plastics JSC
VN:BMP
|
-0.066x |
|
Tatva Chintan Pharma Chem Limited
NSE:TATVA
|
0.017x |
|
Curro Hol
JSE:COH
|
0.097x |
|
DEE Development Eng Ltd
NSE:DEEDEV
|
0.004x |
Annual Cash Flow Conversion Efficiency for Polynovo Ltd (1999–2025)
The table below shows the annual cash flow conversion efficiency of Polynovo Ltd from 1999 to 2025. Review free cash flow generation of Polynovo Ltd to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$83.26 Million ≈ $58.91 Million |
AU$3.15 Million ≈ $2.23 Million |
0.038x | -25.96% |
| 2024-06-30 | AU$72.12 Million ≈ $51.03 Million |
AU$3.68 Million ≈ $2.61 Million |
0.051x | +156.27% |
| 2023-06-30 | AU$65.38 Million ≈ $46.26 Million |
AU$-5.93 Million ≈ $-4.20 Million |
-0.091x | +21.84% |
| 2022-06-30 | AU$17.72 Million ≈ $12.53 Million |
AU$-2.06 Million ≈ $-1.46 Million |
-0.116x | -943.25% |
| 2021-06-30 | AU$22.35 Million ≈ $15.82 Million |
AU$-248.74K ≈ $-176.00K |
-0.011x | +34.18% |
| 2020-06-30 | AU$23.81 Million ≈ $16.85 Million |
AU$-402.56K ≈ $-284.84K |
-0.017x | +86.91% |
| 2019-06-30 | AU$26.10 Million ≈ $18.47 Million |
AU$-3.37 Million ≈ $-2.38 Million |
-0.129x | +46.58% |
| 2018-06-30 | AU$28.46 Million ≈ $20.14 Million |
AU$-6.88 Million ≈ $-4.87 Million |
-0.242x | +49.37% |
| 2017-06-30 | AU$10.81 Million ≈ $7.65 Million |
AU$-5.16 Million ≈ $-3.65 Million |
-0.477x | -102.83% |
| 2016-06-30 | AU$15.11 Million ≈ $10.69 Million |
AU$-3.56 Million ≈ $-2.52 Million |
-0.235x | +32.23% |
| 2015-06-30 | AU$7.39 Million ≈ $5.23 Million |
AU$-2.57 Million ≈ $-1.82 Million |
-0.347x | -15.20% |
| 2014-06-30 | AU$8.67 Million ≈ $6.13 Million |
AU$-2.61 Million ≈ $-1.85 Million |
-0.301x | -1.32% |
| 2013-06-30 | AU$7.82 Million ≈ $5.53 Million |
AU$-2.33 Million ≈ $-1.65 Million |
-0.298x | +10.85% |
| 2012-06-30 | AU$7.99 Million ≈ $5.65 Million |
AU$-2.67 Million ≈ $-1.89 Million |
-0.334x | -21.19% |
| 2011-06-30 | AU$10.64 Million ≈ $7.53 Million |
AU$-2.93 Million ≈ $-2.07 Million |
-0.275x | -33.67% |
| 2010-06-30 | AU$13.74 Million ≈ $9.72 Million |
AU$-2.83 Million ≈ $-2.00 Million |
-0.206x | +4.61% |
| 2009-06-30 | AU$15.82 Million ≈ $11.20 Million |
AU$-3.42 Million ≈ $-2.42 Million |
-0.216x | +13.55% |
| 2008-06-30 | AU$16.46 Million ≈ $11.65 Million |
AU$-4.11 Million ≈ $-2.91 Million |
-0.250x | +61.32% |
| 2007-06-30 | AU$20.79 Million ≈ $14.71 Million |
AU$-13.42 Million ≈ $-9.50 Million |
-0.646x | -45.42% |
| 2006-06-30 | AU$22.76 Million ≈ $16.11 Million |
AU$-10.11 Million ≈ $-7.15 Million |
-0.444x | +27.96% |
| 2005-06-30 | AU$17.28 Million ≈ $12.23 Million |
AU$-10.65 Million ≈ $-7.54 Million |
-0.616x | -15.86% |
| 2004-06-30 | AU$16.68 Million ≈ $11.81 Million |
AU$-8.88 Million ≈ $-6.28 Million |
-0.532x | +57.46% |
| 2003-06-30 | AU$6.26 Million ≈ $4.43 Million |
AU$-7.83 Million ≈ $-5.54 Million |
-1.251x | -221.74% |
| 2002-06-30 | AU$12.15 Million ≈ $8.60 Million |
AU$-4.72 Million ≈ $-3.34 Million |
-0.389x | +47.32% |
| 2001-06-30 | AU$6.41 Million ≈ $4.53 Million |
AU$-4.73 Million ≈ $-3.35 Million |
-0.738x | -147.23% |
| 2000-06-30 | AU$11.46 Million ≈ $8.11 Million |
AU$-3.42 Million ≈ $-2.42 Million |
-0.298x | -46.78% |
| 1999-06-30 | AU$6.66 Million ≈ $4.71 Million |
AU$-1.35 Million ≈ $-957.66K |
-0.203x | -- |
About Polynovo Ltd
PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, and Hong Kong. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn. It is also developing hernia devices for her… Read more